Global Custom Market Research Reports Provider Company

phone

Medpace Holdings Inc (MEDP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • Published Date: 07 Sep 2018
  • Number of Pages: 46
  • Category: Company Profile
  • Country: United States of America
Summary

Medpace Holdings Inc (Medpace) is a scientifically-driven full-service clinical contract research organization. It provides Phase I-IV outsourced clinical development services. The company also offers clinical pharmacology; and supporting laboratory services including central laboratory, bioanalytical, core lab, and imaging core labs. Medpace carries out clinical trials across all the therapeutic areas, including cardiology, metabolic disease, endocrinology, central nervous system (CNS), oncology, and antiviral and anti-infective (AVAI). It serves biopharmaceutical, pharmaceutical, biotechnology, and medical device companies in North America, Europe, Africa, Asia Pacific, and Latin America. The company has specialized esoteric testing offices in the US, China, Belgium, and Singapore. Medpace is headquartered in Cincinnati, Ohio, the US.

Medpace Holdings Inc (MEDP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons To Buy


Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.
Publisher Name : GlobalData

3
List of Tables 4
List of Figures 4
Medpace Holdings Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Medpace Holdings Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Medpace Holdings Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Medpace Holdings Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Medpace Holdings Inc, Medical Devices Deals, 2012 to YTD 2018 9
Medpace Holdings Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Medpace Holdings Inc, Pharmaceuticals & Healthcare, Deal Details 11
Private Equity 11
Cinven Acquires Medpace from CCMP Capital Advisors for USD915 Million 11
Partnerships 13
Actinium Pharma Enters into Agreement with Medpace 13
Medpace Enters into Amendment Agreement with Xenon Pharma 14
Medpace Enters into Agreement with Symplmed Pharmaceuticals 15
Equity Offering 16
Medpace Holdings Prices Public Offering of Shares for USD290 Million 16
Medpace Holdings Prices Public Offering of Shares for USD247.5 Million 18
Medpace Holdings Prices Public Offering of Shares for USD130.5 Million 20
Medpace Raises USD126 Million in Secondary Offering of Shares 21
Medpace Raises USD185.2 Million in IPO 22
Coherus BioSciences Raises USD2.5 Million in Private Placement of Shares 24
Medpace Holdings Inc - Key Competitors 25
Medpace Holdings Inc - Key Employees 26
Medpace Holdings Inc - Locations And Subsidiaries 28
Head Office 28
Other Locations & Subsidiaries 28
Recent Developments 30
Financial Announcements 30
Jul 30, 2018: Medpace Holdings Reports Second Quarter 2018 Results 30
Apr 30, 2018: Medpace Holdings Announces First Quarter 2018 Financial Results 32
Feb 26, 2018: Medpace Holdings Reports Fourth Quarter 2017 Financial Results 34
Oct 30, 2017: Medpace Holdings Reports Third Quarter 2017 Results 36
Jul 31, 2017: Medpace Holdings Reports Second Quarter 2017 Results 37
May 01, 2017: Medpace Holdings Reports First Quarter 2017 Results 38
Feb 27, 2017: Medpace Holdings Reports Fourth Quarter and Full Year 2016 Results 40
Corporate Communications 42
Mar 15, 2018: Medpace Appoints William John As Senior Medical Director 42
Government and Public Interest 43
May 10, 2018: Medpaces Flagship Site Programme for High-Achieving Sites Exemplifies Commitment to Accelerating Clinical Research 43
Mar 27, 2018: Leading CROs Form New Industry Standards Group to Improve Collaboration with Sponsors 44
Appendix 46
Methodology 46
About GlobalData 46
Contact Us 46
Disclaimer 46

List Of Tables


Medpace Holdings Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Medpace Holdings Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Medpace Holdings Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Medpace Holdings Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Medpace Holdings Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Medpace Holdings Inc, Medical Devices Deals, 2012 to YTD 2018 9
Medpace Holdings Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Cinven Acquires Medpace from CCMP Capital Advisors for USD915 Million 11
Actinium Pharma Enters into Agreement with Medpace 13
Medpace Enters into Amendment Agreement with Xenon Pharma 14
Medpace Enters into Agreement with Symplmed Pharmaceuticals 15
Medpace Holdings Prices Public Offering of Shares for USD290 Million 16
Medpace Holdings Prices Public Offering of Shares for USD247.5 Million 18
Medpace Holdings Prices Public Offering of Shares for USD130.5 Million 20
Medpace Raises USD126 Million in Secondary Offering of Shares 21
Medpace Raises USD185.2 Million in IPO 22
Coherus BioSciences Raises USD2.5 Million in Private Placement of Shares 24
Medpace Holdings Inc, Key Competitors 25
Medpace Holdings Inc, Key Employees 26
Medpace Holdings Inc, Other Locations 28
Medpace Holdings Inc, Subsidiaries 29

List Of Figures


Medpace Holdings Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Medpace Holdings Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Medpace Holdings Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Medpace Holdings Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Medpace Holdings Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Medpace Holdings Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Medpace Holdings Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Medpace Holdings Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Medpace Holdings Inc, Medical Devices Deals, 2012 to YTD 2018 9

SELLAS Life Sciences Group Inc (SELLAS), formerly Galena Biopharma Inc, is a clinical-stage biopharmaceutical company that develops novel cancer immunotherapeutics for a broad range of cancer indications. Its lead product

View Report

Qinghai Gelatin Co Ltd (Qinghai Gelatin) is a manufacturer and distributor of gelatin products. The companys product portfolio includes gelatin series, hard capsule series, soft capsule series, casing series, pharmaceutical

View Report

Arrogene Inc (Arrogene) is a developer of cancer therapeutics and imaging products. The company develops nanomedicine products for the treatment of primary brain, lung, and triple negative breast cancer, and

View Report
There is no reviews available for this report

Select License Type

Delivery Details

Delivery Details : Electronic files (PDF) of market research reports will dispatched within 12 to 24 hours. (Mon-Fri IST)

Customized Report

If a particular report is not as per your requirement you can ‎choose "Customized Report". To visit click on -

Custom Research Reports